These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3263222)

  • 1. Qualitative study of fecal alpha 1-proteinase inhibitor in normal subjects and patients with Crohn's disease.
    Mizon C; Becuwe C; Balduyck M; Colombel JF; Cortot A; Mizon J; Degand P
    Clin Chem; 1988 Nov; 34(11):2268-70. PubMed ID: 3263222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deglycosylation of alpha 1-proteinase inhibitor is impaired in the faeces of patients with active inflammatory bowel disease (Crohn's disease).
    Mizon C; el Yamani J; Colombel JF; Maes P; Balduyck M; Laine A; Cortot A; Tartar A; Mizon J
    Clin Sci (Lond); 1991 May; 80(5):517-23. PubMed ID: 1851694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteric protein loss measured by fecal alpha 1-antitrypsin clearance in the assessment of Crohn's disease activity: a study of children and adolescents.
    Griffiths AM; Drobnies A; Soldin SJ; Hamilton JR
    J Pediatr Gastroenterol Nutr; 1986; 5(6):907-11. PubMed ID: 3491890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal alpha 1-antitrypsin excretion in young people with Crohn's disease.
    Thomas DW; Sinatra FR; Merritt RJ
    J Pediatr Gastroenterol Nutr; 1983; 2(3):491-6. PubMed ID: 6604798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Qualitative study of fecal alpha-1-antitrypsin in patients with inflammatory digestive disease and patients with ileostomy].
    Colombel JF; Mizon C; Chekkouri N; Balduyck M; Chaussade S; Becuwe C; Degand P; Mizon J; Cortot A
    Gastroenterol Clin Biol; 1991; 15(4):301-5. PubMed ID: 2060740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal alpha 1-antitrypsin clearance as a marker of clinical relapse in patients with Crohn's disease of the distal ileum.
    Biancone L; Fantini M; Tosti C; Bozzi R; Vavassori P; Pallone F
    Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):261-6. PubMed ID: 12610321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity.
    Meyers S; Wolke A; Field SP; Feuer EJ; Johnson JW; Janowitz HD
    Gastroenterology; 1985 Jul; 89(1):13-8. PubMed ID: 3874110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal alpha 1-antitrypsin as a measure of Crohn's disease activity. The effect of therapy and anatomical extent of disease.
    Meyers S; Lichtiger S; Feuer EJ; Lahman EA; Janowitz HD
    J Clin Gastroenterol; 1988 Oct; 10(5):491-7. PubMed ID: 3263408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fecal excretion and the clearance of alpha 1-antitrypsin in patients with Crohn's disease].
    López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD
    Rev Esp Enferm Dig; 1993 Apr; 83(4):235-9. PubMed ID: 8494651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple method for the measurement of different forms of alpha 1 proteinase inhibitor in the faeces of patients with Crohn's disease.
    el Yamani J; Soudan B; Mizon C; Colombel JF; Balduyck M; Cortot A; Mizon J
    Ann Clin Biochem; 1992 Jul; 29 ( Pt 4)():418-21. PubMed ID: 1642448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural heterogeneity of faecal alpha 1 antitrypsin shown by immunoblot analysis in patients with Crohn's disease.
    Boege F; Fischbach W
    Gut; 1991 May; 32(5):496-9. PubMed ID: 2040471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of ulcerative colitis and Crohn's disease activity by measurement of alpha-1-antitrypsin intestinal clearance (author's transl)].
    Florent C; L'Hirondel C; Desmazures C; Giraudeaux V; Bernier JJ
    Gastroenterol Clin Biol; 1981 Feb; 5(2):193-7. PubMed ID: 6970700
    [No Abstract]   [Full Text] [Related]  

  • 13. [Initial personal experiences with alpha-1-antitrypsin determination in feces].
    Schwery S; Meyenberger C; Ammann R; Wirth HP
    Schweiz Med Wochenschr; 1995 Sep; 125(38):1783-7. PubMed ID: 7481635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings.
    Sipponen T; Savilahti E; Kolho KL; Nuutinen H; Turunen U; Färkkilä M
    Inflamm Bowel Dis; 2008 Jan; 14(1):40-6. PubMed ID: 18022866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease.
    Karbach U; Ewe K; Bodenstein H
    Gut; 1983 Aug; 24(8):718-23. PubMed ID: 6603392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal excretion of alpha 1-antitrypsin in patients with Crohn's disease. A comparison of nephelometry and radial immunodiffusion.
    López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD
    Dig Dis Sci; 1994 Mar; 39(3):507-12. PubMed ID: 8131686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of fecal alpha 1-antitrypsin clearance and fecal concentration as early indicator of postoperative asymptomatic recurrence in Crohn's disease.
    Boirivant M; Pallone F; Ciaco A; Leoni M; Fais S; Torsoli A
    Dig Dis Sci; 1991 Mar; 36(3):347-52. PubMed ID: 1995272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual fecal alpha 1-antitrypsin excretion reflects clinical activity in Crohn's disease but not in ulcerative colitis.
    Becker K; Berger M; Niederau C; Frieling T
    Hepatogastroenterology; 1999; 46(28):2309-14. PubMed ID: 10521988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doppler sonography evaluation of superior mesenteric artery flow to assess Crohn's disease activity: correlation with clinical evaluation, Crohn's disease activity index, and alpha 1-antitrypsin clearance in feces.
    van Oostayen JA; Wasser MN; van Hogezand RA; Griffioen G; Biemond I; Lamers CB; de Roos A
    AJR Am J Roentgenol; 1997 Feb; 168(2):429-33. PubMed ID: 9016220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased faecal exoglycosidase activities identify a subset of patients with active Crohn's disease.
    el Yamani J; Mizon C; Capon C; Colombel JF; Fournet B; Cortot A; Mizon J
    Clin Sci (Lond); 1992 Oct; 83(4):409-15. PubMed ID: 1330402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.